Skip to main content
RA

RareCyte

Seattle, United States
Last funding
$20.0M
Venture - Series UnknownJun 2024

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Backed byArboretum Ventures5AM VenturesAgilent TechnologiesHealthQuest CapitalThe Forest Road Company

About RareCyte

How much funding has RareCyte raised?

RareCyte has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Who are RareCyte's investors?

RareCyte's investors include Arboretum Ventures, 5AM Ventures, Agilent Technologies, HealthQuest Capital, The Forest Road Company.

Where is RareCyte headquartered?

RareCyte is headquartered in Seattle, United States.

What does RareCyte do?

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

What stage is RareCyte at?

RareCyte is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"RareCyte — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/rarecyte. Accessed November 15, 2026.
APA
VCBacked. (2024). RareCyte — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/rarecyte
Wikipedia (cite web)
{{cite web |title=RareCyte — Funding & Investors |url=https://www.vcbacked.co/company/rarecyte |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at RareCyte? Request a listing update

Founder contacts
m***@rarecyte.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →